These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 18036776)

  • 1. Tetra-Primer ARMS PCR Optimization for Detection of IVS-II-I (G-A) and FSC 8/9 InsG Mutations in β-Thalassemia Major Patients in Isfahan Population.
    Hajihoseini S; Motovali-Bashi M; Honardoost MA; Alerasool N
    Iran J Public Health; 2015 Mar; 44(3):380-7. PubMed ID: 25905082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotyping Zebrafish Point Mutant by Allele-Specific Blocking PCR.
    Beh LK; Shen H
    Zebrafish; 2024 May; ():. PubMed ID: 38808506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of PCR-ELISA in molecular diagnosis.
    Sue MJ; Yeap SK; Omar AR; Tan SW
    Biomed Res Int; 2014; 2014():653014. PubMed ID: 24971343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient detection of Mediterranean β-thalassemia mutations by multiplex single-nucleotide primer extension.
    Atanasovska B; Bozhinovski G; Plaseska-Karanfilska D; Chakalova L
    PLoS One; 2012; 7(10):e48167. PubMed ID: 23110203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCR-ELISA for high-throughput blood group genotyping.
    St-Louis M
    Methods Mol Biol; 2009; 496():3-13. PubMed ID: 18839100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran.
    Kiani AA; Mortazavi Y; Zeinali S; Shirkhani Y
    Hemoglobin; 2007; 31(3):343-9. PubMed ID: 17654071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the frameshift codons 8/9 (+G) [FSC 8/9 (+G)] beta-thalassemia mutation, detected by the polymerase chain reaction-amplification refractory mutation system, really FSC 8/9 (+G)?
    Haghi M; Feizi AA; Feizi MA; Pouladi N; Basak AN
    Hemoglobin; 2009; 33(3):279-82. PubMed ID: 19657845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients.
    El-Gawhary S; El-Shafie S; Niazi M; Aziz M; El-Beshlawy A
    Hemoglobin; 2007; 31(1):63-9. PubMed ID: 17365006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
    Darwish HM; El-Khatib FF; Ayesh S
    Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular spectrum of beta-thalassemia mutations in Northwestern Iran.
    Hosseinpour Feizi MA; Hosseinpour Feizi AA; Pouladi N; Haghi M; Azarfam P
    Hemoglobin; 2008; 32(3):255-61. PubMed ID: 18473241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of four beta-thalassemia point mutations in Iranians using a PCR-ELISA genotyping system.
    Gill P; Forouzandeh M; Eshraghi N; Ghalami M; Safa M; Noori-Daloii MR
    Mol Cell Probes; 2008 Apr; 22(2):103-9. PubMed ID: 18036776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thalassemia].
    Hattori Y
    Rinsho Byori; 1995 Aug; 43(8):776-80. PubMed ID: 7474435
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.